Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$26.2 - $54.0 $325,299 - $670,464
-12,416 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$38.58 - $83.27 $80,014 - $172,701
-2,074 Reduced 14.31%
12,416 $613,000
Q4 2021

Feb 14, 2022

BUY
$75.47 - $135.88 $54,413 - $97,969
721 Added 5.24%
14,490 $1.12 Million
Q3 2021

Nov 15, 2021

BUY
$95.64 - $131.48 $176,742 - $242,975
1,848 Added 15.5%
13,769 $1.47 Million
Q2 2021

Aug 12, 2021

BUY
$88.13 - $142.06 $109,898 - $177,148
1,247 Added 11.68%
11,921 $1.59 Million
Q1 2021

May 17, 2021

BUY
$105.48 - $207.97 $318,127 - $627,237
3,016 Added 39.38%
10,674 $1.32 Million
Q4 2020

Feb 19, 2021

BUY
$76.64 - $167.89 $586,909 - $1.29 Million
7,658 New
7,658 $1.08 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.45B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Aton Ra Partners Portfolio

Follow Aton Ra Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.